Valerie Hildebrand
Nurse Practitioner · Flowood, MSNPI 1548643802
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$662
- Sumitomo Pharma America, Inc.$345
- AbbVie$300
- Currax Pharmaceuticals LLC$241
- Takeda Pharmaceuticals U.S.A., Inc.$214
- Astellas Pharma Global Development$204
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,04797%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 21 | $662 |
| Sumitomo Pharma America, Inc. | 13 | $345 |
| AbbVie(2 entities) | 19 | $300 |
| Currax Pharmaceuticals LLC | 15 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $214 |
| Astellas Pharma Global Development | 3 | $204 |
| Eisai Inc. | 12 | $180 |
| Mayne Pharma Commercial LLC | 14 | $174 |
| Axonics, Inc. | 2 | $158 |
| Axsome Therapeutics, Inc. | 2 | $138 |
| Therapeuticsmd, Inc. | 4 | $79 |
| Novo Nordisk | 5 | $75 |
| Urovant Sciences Inc | 4 | $65 |
| Acella Pharmaceuticals, LLC | 3 | $57 |
| Lilly USA, LLC | 3 | $52 |
| Evofem Biosciences, Inc. | 3 | $50 |
| Bausch Health US, LLC | 2 | $36 |
| Pfizer | 2 | $29 |
| Abbott | 1 | $24 |
| Myovant Sciences Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Mission Pharmacal Company | 1 | $16 |
| Hollister Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,147 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 35 | $2,122 |
| ProgesteroneProgesterone, Micronized | 55 | $961 |
| Spironolactone | 21 | $46 |
| Levothyroxine Sodium | 20 | $12 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Flowood
- Sara KlausFlowood$48K
- Callie HallFlowood$7K
- Carmen CarrFlowood$6K
- Amanda SullivanFlowood$5K
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.